|
1
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Niklinski J, Niklinska W, Chyczewski L,
Becker HD and Pluygers E: Molecular genetic abnormalities in
premalignant lung lesions: Biological and clinical implications.
Eur J Cancer Prev. 10:213–226. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou J, Song XB, He H, Zhou Y, Lu XJ and
Ying BW: Prevalence and clinical profile of EGFR mutation in
non-small-cell lung carcinoma patients in Southwest China. Asian
Pac J Cancer Prev. 17:965–971. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu S, Zhao X, Wu S, Du R, Zhu Q, Fang H,
Zhang X, Zhang C, Zheng W, Yang J and Feng H: Overexpression of
B7-H3 correlates with aggressive clinicopathological
characteristics in non-small cell lung cancer. Oncotarget.
7:81750–81756. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mendell JT: MicroRNAs: Critical regulators
of development, cellular physiology and malignancy. Cell Cycle.
4:1179–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu T, Wu X, Chen T, Luo Z and Hu X:
Downregulation of DNMT3A by miR-708-5p inhibits lung cancer stem
cell-like phenotypes through repressing wnt/β-catenin signaling.
Clin Cancer Res. 24:1748–1760. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang W, Tian X, Bai F, Han R, Wang J, Shen
H, Zhang X, Liu Y, Yan X, Jiang F and Xing L: Pim-1 kinase is a
target of miR-486-5p and eukaryotic translation initiation factor
4E, and plays a critical role in lung cancer. Mol Cancer.
13:2402014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paliouras AR, Monteverde T and Garofalo M:
Oncogene-induced regulation of microRNA expression: Implications
for cancer initiation, progression and therapy. Cancer Lett.
421:152–160. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fadejeva I, Olschewski H and Hrzenjak A:
MicroRNAs as regulators of cisplatin-resistance in non-small cell
lung carcinomas. Oncotarget. 8:115754–115773. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li S, Gao M, Li Z, Song L, Gao X, Han J,
Wang F, Chen Y, Li W, Yang J and Han X: Role of microRNAs in
metastasis of non-small cell lung cancer. Front Biosci (Landmark
Ed). 21:998–1005. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Q, Huang SX, Zhang F, Li SJ, Liu C,
Xi YY, Wang L, Wang X, He QQ, Sun CC and Li DJ: MicroRNAs: A novel
potential biomarker for diagnosis and therapy in patients with
non-small cell lung cancer. Cell Prolif. 50:123942017. View Article : Google Scholar
|
|
14
|
Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen
YY, Wang WJ, Chen Q, Tang F, Liu XP and Xu ZD: Involvement of
NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced
epithelial-mesenchymal transition of breast cancer cells. Cell
Death Differ. 18:16–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu H, Zhou X, Ma C, Chang H, Li H, Liu F
and Lu J: Low expression of miR-448 induces EMT and promotes
invasion by regulating ROCK2 in hepatocellular carcinoma. Cell
Physiol Biochem. 36:487–498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li B, Ge L, Li M, Wang L and Li Z: miR-448
suppresses proliferation and invasion by regulating IGF1R in
colorectal cancer cells. Am J Transl Res. 8:3013–3022.
2016.PubMed/NCBI
|
|
17
|
Shan C, Fei F, Li F, Zhuang B, Zheng Y,
Wan Y and Chen J: miR-448 is a novel prognostic factor of lung
squamous cell carcinoma and regulates cells growth and metastasis
by targeting DCLK1. Biomed Pharmacother. 89:1227–1234. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bordone L and Guarente L: Calorie
restriction, SIRT1 and metabolism: Understanding longevity. Nat Rev
Mol Cell Biol. 6:298–305. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ong ALC and Ramasamy TS: Role of
Sirtuin1-p53 regulatory axis in aging, cancer and cellular
reprogramming. Ageing Res Rev. 43:64–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu T, Liu PY and Marshall GM: The
critical role of the class III histone deacetylase SIRT1 in cancer.
Cancer Res. 69:1702–1705. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Xu S, Li J, Zheng L, Feng M, Wang X,
Han K, Pi H, Li M, Huang X, et al: SIRT1 facilitates hepatocellular
carcinoma metastasis by promoting PGC-1α-mediated mitochondrial
biogenesis. Oncotarget. 7:29255–29274. 2016.PubMed/NCBI
|
|
22
|
Zou Q, Tang Q, Pan Y, Wang X, Dong X,
Liang Z and Huang D: MicroRNA-22 inhibits cell growth and
metastasis in breast cancer via targeting of SIRT1. Exp Ther Med.
14:1009–1016. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y, Wang T, Wang W, Hu J, Li R, He S
and Yang J: Prognostic and clinicopathological significance of
SIRT1 expression in NSCLC: A meta-analysis. Oncotarget.
8:62537–62544. 2017.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye Z, Fang B, Pan J, Zhang N, Huang J, Xie
C, Lou T and Cao Z: miR-138 suppresses the proliferation,
metastasis and autophagy of non-small cell lung cancer by targeting
Sirt1. Oncol Rep. 37:3244–3252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X, Shao K and Sun T: SIRT1 regulates
the human alveolar epithelial A549 cell apoptosis induced by
pseudomonas aeruginosa lipopolysaccharide. Cell Physiol Biochem.
31:92–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Powrozek T, Krawczyk P, Kowalski DM,
Kuźnar-Kamińska B, Winiarczyk K, Olszyna-Serementa M,
Batura-Gabryel H and Milanowski J: Application of plasma
circulating microRNA-448, 506, 4316, and 4478 analysis for
non-invasive diagnosis of lung cancer. Tumour Biol. 37:2049–2055.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guan Y, Rao Z and Chen C: miR-30a
suppresses lung cancer progression by targeting SIRT1. Oncotarget.
9:4924–4934. 2017.PubMed/NCBI
|
|
29
|
Li T, Ma J, Han X, Jia Y, Yuan H, Shui S
and Guo D: MicroRNA-320 enhances radiosensitivity of glioma through
down-regulation of sirtuin type 1 by directly targeting forkhead
box protein M1. Transl Oncol. 11:205–212. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Wang DS, Cheng YS, Jia BL, Yu G,
Yin XQ and Wang Y: Expression of MicroRNA-448 and SIRT1 and
prognosis of obese type 2 diabetic mellitus patients after
laparoscopic bariatric surgery. Cell Physiol Biochem. 45:935–950.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu X, Yan L, Liu Y, Xian W, Wang L and
Ding X: MicroRNA-448 suppresses osteosarcoma cell proliferation and
invasion through targeting EPHA7. PLoS One. 12:e01755532017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun T, Jiao L, Wang Y, Yu Y and Ming L:
SIRT1 induces epithelial-mesenchymal transition by promoting
autophagic degradation of E-cadherin in melanoma cells. Cell Death
Dis. 9:1362018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ray U, Roy SS and Chowdhury SR:
Lysophosphatidic acid promotes epithelial to mesenchymal transition
in ovarian cancer cells by repressing SIRT1. Cell Physiol Biochem.
41:795–805. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma P, Ni K, Ke J, Zhang W, Feng Y and Mao
Q: miR-448 inhibits the epithelial-mesenchymal transition in breast
cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Exp Biol Med (Maywood). 243:473–480. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
